drugset / Trial / NCT00176059

Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

NCT00176059

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this randomized prospective study in renal transplant recipients is to investigate immunological short and long-term effects of an IVIG induction therapy. Furthermore clinical endpoints (patient and graft survival, incidence of acute and chronic rejection, infectious diseases and graft function) up to three years posttransplant will be analyzed.

Timeline

Start
2001-10
Primary completion
Completion
2006-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Immune Globulin Intravenous (Human) Protein / enzyme biologic 10 g Intravenous